Celltrion
Celltrion, officially known as Celltrion Healthcare Co., Ltd., is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in South Korea (KR). Founded in 2002, the company has rapidly evolved, establishing itself as a leader in biopharmaceuticals, particularly in the development and production of monoclonal antibodies and biosimilars.
With a strong operational presence in Europe, the Americas, and Asia, Celltrion focuses on innovative therapies for autoimmune diseases, cancer, and infectious diseases. Its core products, including Remsima and Truxima, are distinguished by their high quality and efficacy, setting new standards in patient care. Recognised for its commitment to research and development, Celltrion has achieved significant milestones, including regulatory approvals in multiple regions, solidifying its market position as a trusted provider of advanced therapeutic solutions.
+18 vs industry average
Celltrion’s score of 57 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Celltrion?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Celltrion's reported carbon emissions
Celltrion, a pharmaceutical preparation manufacturing company headquartered in South Korea (KR), has reported its carbon emissions across various scopes.
For the reporting year 2024, Celltrion's total global GHG emissions were approximately 119,608,000 kg CO2e. This comprises Scope 1 emissions of about 27,146,000 kg CO2e, Scope 2 emissions of approximately 52,028,000 kg CO2e (location-based), and Scope 3 emissions totalling around 42,426,000 kg CO2e. Within Scope 3, upstream transportation and distribution accounted for the largest portion at approximately 18,122,000 kg CO2e, followed by downstream transportation and distribution at about 26,939,000 kg CO2e.
In 2023, Celltrion's total global GHG emissions were approximately 93,755,000 kg CO2e. This included Scope 1 emissions of approximately 22,457,000 kg CO2e, Scope 2 emissions of about 42,260,000 kg CO2e, and Scope 3 emissions totalling approximately 28,798,000 kg CO2e.
Celltrion is actively pursuing emission reduction initiatives. The company has set a target to achieve carbon neutrality by 2050. More imminently, Celltrion aims to reduce its GHG emissions by 50% by 2030, using 2020 as a baseline. Furthermore, Celltrion and Celltrion Pharm have announced a Net Zero commitment targeting a reduction of Scope 1 and 2 emissions by 42% by 2030 and 100% by 2045, using 2022 as the base year for their domestic operations.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Celltrion’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
7 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project